MYRIAM JOSEPH: Open Payments
NPI 1427283944 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 19 payments from 4 companies in 2025. Trend: 2023 $49 · 2024 $568 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $246 |
| ViiV Healthcare Company | 9 | $206 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
Products named: DOVATO, Yeztugo, PIFELTRO, UZEDY, APRETUDE, CABENUVA.
Industry payments across NY — which companies pay providers there.
